STOCKS at state drug procurer, the National Pharmaceutical Company (NatPharm), have gone up due to improvements in local production, the government says. This comes after NatPharm earlier this year announced that it was now prioritising procurement from local medicine manufacturing companies to avoid unnecessary imports. “In terms of materials production, the Cabinet advises that there…
Subscribe to read full article. Subscribe today